ARCHIVES

Gregory Reaman Named Associate Director of FDA Office of Oncology Drug Products

This article is from The Cancer Letter archive.

Vol. 37 No. 22 | June 3, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: Subcommittee Adds $16-18 Million o NVI Budget; Upton Might Leave If Bill Fails

May 25, 1979

NCI Advisors Set SPORE Review Criteria, Approve Plan To Fund New Ovarian Grant

June 26, 1998

ASCO Issues RFP To Establish Washington Office

August 11, 1989

In Brief: Centers Awarded Gifts; Georgetown Launches $40m Campaign; Herberman Named To PA Board

February 1, 1991

ORI Says COMS Study Coordinator Committed Scientific Misconduct

April 12, 1996

In Brief: Online Genetics Glossary; ORI Misconduct Finding

February 5, 1999